Cipher Pharmaceuticals Inc. to present at the 2014 Bloom Burton & Co. Healthcare Investor Conference

About this update from Cipher Pharmaceuticals Inc.

[{"type":"text","content":"\n\n\nMISSISSAUGA, ON, June 5, 2014 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:\n DND) (\"Cipher\" or \"the Company\") today announced that Norm Evans, Chief\n Financial Officer, is presenting at the 2014 Bloom Burton & Co.\n Healthcare Investor Conference, which is being held at the Toronto\n Board of Trade. Mr. Evans will provide a corporate update on Wednesday,\n June 18, 2014 at 10:00 AM ET followed by a Q&A session.\n\n\nTo learn more about the 2014 Bloom Burton & Co. Healthcare Investor\n Conference please visit their website http://bit.ly/cipherbloomburton\n\n\nAbout Cipher Pharmaceuticals Inc.\n\n\nCipher Pharmaceuticals (TSX: DND) is a growing specialty pharmaceutical\n company with three commercial products and a fourth in development. Our\n product candidates are typically improved formulations of successful,\n currently marketed drugs. We in-license a product, manage the required\n clinical development and regulatory approval process, and either\n out-license it to a marketing partner, or, in Canada, we may market the\n product ourselves. Our core capabilities are in clinical and regulatory\n affairs, product licensing, supply chain management, and marketing and\n sales. Since the Company was founded in 2000, we have achieved final\n regulatory approval in the U.S. and Canada for all three of our\n original products and completed six marketing partnerships, generating\n growing licensing revenue.\n\n\nSOURCE Cipher Pharmaceuticals Inc.\n\n\n\n For more information, please contact:  Craig Armitage Investor Relations TMX Equicom (416) 815-0700 ext 278 (416) 815-0080 fax [email protected] Norm Evans Chief Financial Officer Cipher Pharmaceuticals (905) 602-5840 ext 323 (905) 602-0628 fax [email protected] Copyright CNW Group 2014","length":2657,"tagName":"div"}]

More updates from Cipher Pharmaceuticals Inc.